IP Library Granted Patent US 8,119,348
Granted Patent B2
US 8,119,348 · App. 12/834,529 · Granted Feb 21, 2012

Compositions and methods for diagnosing and treating macular degeneration

Assignees: The Regents of the University of Michigan; The Trustees of the University of Pennsylvania; Mayo Foundation for Medical Education and Research
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,119,348
App. No.
12/834,529
Granted
Feb 21, 2012
Kind
B2
Abstract

The present invention relates generally to biomarkers for macular degeneration. In particular, the present invention provides a plurality of biomarkers for monitoring and diagnosing macular degeneration. The compositions and methods of the present invention find use in diagnostic, therapeutic, research, and drug screening applications.

Claims (6)

1. A method for characterizing a human subject as having an increased risk for developing age-related macular degeneration (AMD), said method comprising: detecting in a sample obtained from said subject the presence of at least one A allele of the rs9621532 single nucleotide polymorphism; wherein the presence of at least one A allele of the rs9621532 single nucleotide polymorphism is indicative of an increased risk for developing AMD.

2. The method of claim 1 , further comprising detecting in said sample obtained from said subject the presence of one or more of: at least one A allele of the rs10737680 single nucleotide polymorphism, at least one G allele of the rs3793917 single nucleotide polymorphism, at least one G allele of the rs429608 single nucleotide polymorphism, at least one C allele of the rs2230199 single nucleotide polymorphism, at least one T allele of the rs2285714 single nucleotide polymorphism, at least one T allele of the rs1329424 single nucleotide polymorphism, at least one A allele of the rs9380272 single nucleotide polymorphism, and at least one C allele of the rs493258 single nucleotide polymorphism.

3. The method of claim 2 , wherein said method comprises detecting the presence of two or more of: at least one A allele of the rs10737680 single nucleotide polymorphism, at least one G allele of the rs3793917 single nucleotide polymorphism, at least one G allele of the rs429608 single nucleotide polymorphism, at least one C allele of the rs2230199 single nucleotide polymorphism, at least one T allele of the rs2285714 single nucleotide polymorphism, at least one T allele of the rs1329424 single nucleotide polymorphism, at least one A allele of the rs9380272 single nucleotide polymorphism, and at least one C allele of the rs493258 single nucleotide polymorphism.

4. The method of claim 2 , wherein said method comprises detecting the presence of five or more of: at least one A allele of the rs10737680 single nucleotide polymorphism, at least one G allele of the rs3793917 single nucleotide polymorphism, at least one G allele of the rs429608 single nucleotide polymorphism, at least one C allele of the rs2230199 single nucleotide polymorphism, at least one T allele of the rs2285714 single nucleotide polymorphism, at least one T allele of the rs1329424 single nucleotide polymorphism, at least one A allele of the rs9380272 single nucleotide polymorphism, and at least one C allele of the rs493258 single nucleotide polymorphism.

5. The method of claim 2 , wherein said method comprises detecting the presence of seven or more of: at least one A allele of the rs10737680 single nucleotide polymorphism, at least one G allele of the rs3793917 single nucleotide polymorphism, at least one G allele of the rs429608 single nucleotide polymorphism, at least one C allele of the rs2230199 single nucleotide polymorphism, at least one T allele of the rs2285714 single nucleotide polymorphism, at least one T allele of the rs1329424 single nucleotide polymorphism, at least one A allele of the rs9380272 single nucleotide polymorphism, and at least one C allele of the rs493258 single nucleotide polymorphism.

6. The method of claim 2 , wherein said method comprises detecting the presence of each of: at least one A allele of the rs10737680 single nucleotide polymorphism, at least one G allele of the rs3793917 single nucleotide polymorphism, at least one G allele of the rs429608 single nucleotide polymorphism, at least one C allele of the rs2230199 single nucleotide polymorphism, at least one T allele of the rs2285714 single nucleotide polymorphism, at least one T allele of the rs1329424 single nucleotide polymorphism, at least one A allele of the rs9380272 single nucleotide polymorphism, and at least one C allele of the rs493258 single nucleotide polymorphism.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2016
From: SWAROOP, ANAND; ABECASIS, GONCALO; CHEN, WEI
To: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Reel/Frame 039816/0732 →
CONFIRMATORY LICENSE Recorded Aug 2, 2011
From: UNIVERSITY OF MICHIGAN
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 026683/0931 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 20, 2010
From: STAMBOLIAN, DWIGHT
To: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
Reel/Frame 025170/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2010
From: SWAROOP, ANAND; CHEN, WEI; ABECASIS, GONCALO
To: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Reel/Frame 025023/0321 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2010
From: EDWARDS, ALBERT O.
To: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
Reel/Frame 025023/0331 →
CONFIRMATORY LICENSE Recorded Aug 31, 2010
From: UNIVERSITY OF MICHIGAN
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024913/0422 →
Continuity (2)
Provisional Application 61224753 · Jul 10, 2009
Related Publication 20110014716A1 · Jan 20, 2011